NeuroAge Therapeutics

Recent Finacing

Equity

Recent Raise

$0.3M

NeuroAge Therapeutics develops and validates diagnostic biomarkers for early detection of Alzheimer's disease and related dementias, focusing on biomarker discovery, assay development, and clinical validation.

Founded 2022

California, United States

1-10

Private

neuroagetx.com

Highlights

Focus Areas

Health Care

Health Diagnostics

Recent Investors

Financials

$0.3M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at NeuroAge Therapeutics.